Guru Subramanian Guru Murthy

8PUBLICATIONS
35CO-AUTHORS
Regenerative medicine (incl. stem cells)Haematological tumoursHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 13, 2026
Magrolimab Plus Azacitidine Versus Placebo Plus Azacitidine in Patients With Untreated Higher-Risk Myelodysplastic Syndromes: The Phase III ENHANCE Study.

|Feb 15, 2025
Phase 1 study of lintuzumab-Ac225 combined with CLAG-M salvage therapy in relapsed/refractory acute myeloid leukemia.

Sameem M Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani

|Jan 25, 2024
Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation.

Guru Subramanian Guru Murthy, Tao Zhang, Yung-Tsi Bolon

|Feb 22, 2023
Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND).

Talha Badar, Ehab Atallah, Rory Shallis

|Jan 06, 2023
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.

Guru Subramanian Guru Murthy, Brent R Logan, Stephanie Bo-Subait

|Dec 22, 2022
Disparities in receiving disease-directed therapy, allogeneic stem cell transplantation in non-Hispanic Black patients with TP53-mutated acute myeloid leukemia.

Talha Badar, Mark R Litzow, Rory M Shallis

Pageof 2

Frequent Collaborators

3 joint publications

Talha Badar

3 joint publications

Anand Patel

3 joint publications

Madelyn Burkart

2 joint publications

Jan P Bewersdorf